NERV

Minerva Neurosciences, Inc

$4.91 -1.80%

Recent alerts on NERV

All signals →

News Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates - Zacks Investment Research

News Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

News Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod

News Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

News Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

News Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

News Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

News SAGE's Huntington's Disease Study Meets Primary Endpoint

News Ultragenyx (RARE) Posts New Data From Bone Disease Study

News Ultragenyx (RARE) to Seek Accelerated Nod for Rare Disease Drug

News AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag

News Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion

News Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion

News Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)

News Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why

News Vir Biotechnology (VIR) Up on Positive Data From HDV Study

News Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo

News Corcept (CORT) Rises as Cushing's Syndrome Study Meets Goal

News Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion

News Candel (CADL) Reports Upbeat Data From Lung Cancer Study

News Mirum's (MIRM) Livmarli Aids Sales but Overdependence Concerns

News Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk

News Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08

Scanner Unusual volume (4.0x average)

News Minerva University launches World Wise Executive Leadership Program in Tokyo

Get push alerts for NERV

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS